Patient Access Solutions(PASO)
$0.00+0.00 (+900.00%)
PASO
Patient Access Solutions financials statements
$0.00
At close:+0.00 (+900.00%)
Patient Access Solutions (PASO) Ratios
29 Followers
Patient Access Solutions Ratios
PASO's free cash flow for Q1 2022 was $303.00. For the 2022 fiscal year, PASO's free cash flow was increased by $0.00 and operating cash flow was $303.00. See a summary of the company’s cash flow.
| Ratios | Oct 21 | Oct 20 | Oct 19 | Oct 18 | Oct 17 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.01 | 0.01 | 2.88 | 1.73 | 1.44 |
| Quick Ratio | 0.01 | 0.01 | 2.87 | 1.72 | 1.42 |
| Cash Ratio | 0.01 | 0.01 | 0.06 | -0.08 | -0.23 |
| Solvency Ratio | -4.33 | -3.38 | 0.88 | 0.90 | -1.40 |
| Operating Cash Flow Ratio | -5.37 | 0.07 | 0.18 | -0.84 | -0.00 |
| Short-Term Operating Cash Flow Coverage | -26.14 | 0.19 | 0.23 | -1.13 | -0.00 |
| Net Current Asset Value | $ -2.43M | $ -2.09M | $ 1.37M | $ 566.06K | $ 477.53K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.89 | 1.44 | 0.20 | 0.20 | 0.37 |
| Debt-to-Equity Ratio | -0.47 | -0.64 | 0.28 | 0.47 | 0.72 |
| Debt-to-Capital Ratio | -0.90 | -1.77 | 0.22 | 0.32 | 0.42 |
| Long-Term Debt-to-Capital Ratio | -0.11 | -0.16 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.25 | -0.44 | 1.36 | 2.28 | 1.96 |
| Debt Service Coverage Ratio | -30.61 | -9.70 | 0.83 | 1.21 | -1.76 |
| Interest Coverage Ratio | -3245.89 | -17508.55 | 353.58 | 26.67 | 0.00 |
| Debt to Market Cap | 0.07 | 0.03 | 0.11 | 0.24 | 0.04 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Net Debt to EBITDA | -0.08 | -0.13 | 1.11 | 0.88 | -0.74 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 100.00% | 99.70% | 100.15% | 98.15% |
| EBIT Margin | -5698.09% | -1455.16% | 50.18% | 39.09% | -60.69% |
| EBITDA Margin | -5687.04% | -1414.24% | 50.18% | 39.09% | -58.84% |
| Operating Profit Margin | -4232.52% | -1389.17% | 50.18% | 39.09% | -56.28% |
| Pretax Profit Margin | -4979.71% | -1455.24% | 50.05% | 37.62% | -64.03% |
| Net Profit Margin | -4979.71% | -1455.24% | 50.05% | 37.62% | -64.03% |
| Continuous Operations Profit Margin | -4979.71% | -1455.24% | 50.05% | 37.62% | -64.03% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 117.65% | 104.76% | 99.73% | 96.24% | 113.76% |
| Return on Assets (ROA) | -2165.54% | -1133.77% | 16.92% | 24.86% | -70.48% |
| Return on Equity (ROE) | 541.94% | 501.81% | 22.99% | 56.61% | -138.07% |
| Return on Capital Employed (ROCE) | 633.29% | 554.95% | 23.05% | 35.70% | -121.38% |
| Return on Invested Capital (ROIC) | 874.71% | 1328.95% | 18.05% | 27.83% | -70.54% |
| Return on Tangible Assets | -2165.54% | -1133.77% | 16.92% | 24.86% | -70.48% |
| Earnings Yield | -129.24% | -21.85% | 8.92% | 28.96% | -7.43% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.46 | 1.35 | 1.38 |
| Payables Turnover | 0.00 | 0.00 | 0.02 | -0.02 | 0.44 |
| Inventory Turnover | 0.00 | 0.00 | 0.39 | -0.39 | 2.30 |
| Fixed Asset Turnover | 0.46 | 0.80 | 1.46 | 2.89 | 3.86 |
| Asset Turnover | 0.43 | 0.78 | 0.34 | 0.66 | 1.10 |
| Working Capital Turnover Ratio | -0.11 | -1.93 | 0.97 | 3.56 | 73.53 |
| Cash Conversion Cycle | 0.00 | 0.00 | -15069.42 | 20799.80 | -404.68 |
| Days of Sales Outstanding | 0.00 | 0.00 | 790.12 | 269.70 | 264.16 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 945.67 | -945.71 | 158.41 |
| Days of Payables Outstanding | 0.00 | 0.00 | 16805.21 | -21475.80 | 827.25 |
| Operating Cycle | 0.00 | 0.00 | 1735.79 | -676.01 | 422.57 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | 0.00 | 0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | 0.00 | 0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -2840951.80 | 0.00 | 0.00 | -144.76 | -1.27 |
| Capital Expenditure Coverage Ratio | -2840951.80 | 0.00 | 0.00 | -144.76 | -1.27 |
| Operating Cash Flow Coverage Ratio | -11.08 | 0.15 | 0.23 | -1.13 | -0.00 |
| Operating Cash Flow to Sales Ratio | -48.21 | 0.27 | 0.14 | -0.35 | -0.00 |
| Free Cash Flow Yield | -125.12% | 0.41% | 2.45% | -27.11% | -0.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.77 | -4.58 | 11.21 | 3.45 | -13.46 |
| Price-to-Sales (P/S) Ratio | 38.53 | 66.60 | 5.61 | 1.30 | 8.62 |
| Price-to-Book (P/B) Ratio | -4.19 | -22.97 | 2.58 | 1.95 | 18.59 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.80 | 244.53 | 40.81 | -3.69 | -23505.63 |
| Price-to-Operating Cash Flow Ratio | -0.80 | 244.53 | 40.81 | -3.71 | -41993.44 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | 0.01 | -0.21 | -0.03 | 0.03 |
| Enterprise Value Multiple | -0.75 | -4.84 | 12.29 | 4.20 | -15.39 |
| Enterprise Value | 9.11M | 34.50M | 5.79M | 3.05M | 22.27M |
| EV to EBITDA | -0.75 | -4.84 | 12.29 | 4.20 | -15.39 |
| EV to Sales | 42.81 | 68.43 | 6.17 | 1.64 | 9.06 |
| EV to Free Cash Flow | -0.89 | 251.24 | 44.88 | -4.66 | -24696.13 |
| EV to Operating Cash Flow | -0.89 | 251.24 | 44.88 | -4.69 | -44120.29 |
| Tangible Book Value Per Share | -0.00 | -0.00 | 0.01 | 0.01 | 0.01 |
| Shareholders’ Equity Per Share | -0.00 | -0.00 | 0.01 | 0.00 | 0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 |
| Net Income Per Share | -0.00 | -0.01 | 0.00 | 0.00 | -0.02 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.87 | 1.00 | 1.00 | 0.96 | 1.05 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.97 | -0.02 | 0.27 | -0.93 | 0.30 |
Currency in USD
